Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study of Dideoxyinosine (ddI) in HIV-Infected Children Who Have Not Had Success With Zidovudine or Who Cannot Take Zidovudine

ClinicalTrials.gov ID: NCT00000963

Public ClinicalTrials.gov record NCT00000963. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 10, 2026, 5:35 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Comparative Trial of Two Doses of 2',3'-Dideoxyinosine (ddI) in Children With Symptomatic HIV Infection Who Are Either Unresponsive to Zidovudine and/or Who Are Intolerant to Zidovudine

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the effectiveness, safety, and tolerance of two doses of didanosine (ddI) in the treatment of children with symptomatic HIV disease who have had to discontinue zidovudine (AZT) because of intolerance and/or who have experienced progressive disease while on AZT. The progression of immunodeficiency due to HIV infection can be delayed by using AZT. The benefits of AZT in adults with AIDS and severe AIDS-related complex (ARC) appear to last for approximately 12 to 18 months, at which time most patients have progressive deterioration. Recently published literature has described a reduced sensitivity of HIV isolated from patients after prolonged AZT treatment. Although the clinical significance of this is unclear, it makes the development of new antiretroviral drugs important.

Study identification

NCT ID
NCT00000963
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
300 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
3 Months to 18 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Aug 31, 1995
Last update posted
Oct 28, 2021

Ends 1995

United States locations

U.S. sites
49
U.S. states
18
U.S. cities
36
Facility City State ZIP Site status
Long Beach Memorial Med. Ctr., Miller Children's Hosp. Long Beach California 90801
Usc La Nichd Crs Los Angeles California 90033
UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS Los Angeles California
Children's Hosp. & Research Ctr. Oakland, Ped. Clinical Research Ctr. & Research Lab. Oakland California 94609
UCSD Maternal, Child, and Adolescent HIV CRS San Diego California 92093
UCSF Pediatric AIDS CRS San Francisco California 94143
Harbor - UCLA Med. Ctr. - Dept. of Peds., Div. of Infectious Diseases Torrance California
Univ. of Connecticut Health Ctr., Dept. of Ped. Farmington Connecticut 06032
Yale Univ. School of Medicine - Dept. of Peds., Div. of Infectious Disease New Haven Connecticut 06504
Children's National Med. Ctr., ACTU Washington D.C. District of Columbia 20010
Howard Univ. Washington DC NICHD CRS Washington D.C. District of Columbia 20060
Univ. of Miami Ped. Perinatal HIV/AIDS CRS Miami Florida 33161
Emory Univ. School of Medicine, Dept. of Peds., Div. of Infectious Diseases Atlanta Georgia 30306
Cook County Hosp. Chicago Illinois 60612
Univ. of Illinois College of Medicine at Chicago, Dept. of Peds. Chicago Illinois 60612
Chicago Children's CRS Chicago Illinois 60614
Univ. of Chicago - Dept. of Peds., Div. of Infectious Disease Chicago Illinois 60637
Tulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU New Orleans Louisiana
Tulane/LSU Maternal/Child CRS New Orleans Louisiana
Univ. of Maryland Med. Ctr., Div. of Ped. Immunology & Rheumatology Baltimore Maryland 21201
Johns Hopkins Hosp. & Health System - Dept. of Peds., Div. of Infectious Diseases Baltimore Maryland 21287
HMS - Children's Hosp. Boston, Div. of Infectious Diseases Boston Massachusetts 02115
BMC, Div. of Ped Infectious Diseases Boston Massachusetts 02118
Baystate Health, Baystate Med. Ctr. Springfield Massachusetts 01199
WNE Maternal Pediatric Adolescent AIDS CRS Worcester Massachusetts 01655
Children's Hospital of Michigan NICHD CRS Detroit Michigan 48201
UMDNJ - Robert Wood Johnson New Brunswick New Jersey
St. Joseph's Hosp. & Med. Ctr. of New Jersey Paterson New Jersey
Children's Hospital at Albany Medical Center, Dept. of Peds. Albany New York 12208
SUNY Downstate Med. Ctr., Children's Hosp. at Downstate NICHD CRS Brooklyn New York 11203
North Shore-Long Island Jewish Health System, Dept. of Peds. Great Neck New York 11021
Schneider Children's Hosp., Div. of Infectious Diseases New Hyde Park New York 11040
NYU Med. Ctr., Dept. of Medicine New York New York 10016
Metropolitan Hosp. NICHD CRS New York New York 10029
Columbia IMPAACT CRS New York New York 10032
Incarnation Children's Ctr. New York New York 10032
Harlem Hosp. Ctr. NY NICHD CRS New York New York 10037
Univ. of Rochester ACTG CRS Rochester New York 14642
SUNY Stony Brook NICHD CRS Stony Brook New York 11794
SUNY Upstate Med. Univ., Dept. of Peds. Syracuse New York 13210
Bronx-Lebanon Hosp. IMPAACT CRS The Bronx New York 10457
DUMC Ped. CRS Durham North Carolina 27710
Case CRS Cleveland Ohio 44106
The Children's Hosp. of Philadelphia IMPAACT CRS Philadelphia Pennsylvania 19104
St. Christopher's Hosp. for Children Philadelphia Pennsylvania 19134
Med. Univ. of South Carolina, Div. of Ped. Infectious Diseases Charleston South Carolina 29425
Children's Med. Ctr. Dallas Dallas Texas 75235
Texas Children's Hosp. CRS Houston Texas 77030
UW School of Medicine - CHRMC Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00000963, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 28, 2021 · Synced Sep 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00000963 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →